PWM
INSM icon

Parkworth Wealth Management’s Insmed INSM Stock Holding History

Parkworth Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$101 Sell
1
-2
-67% -$153 ﹤0.01% 1129
2025
Q1 		$229 Hold
3
– – ﹤0.01% 678
2024
Q4 		$207 Buy
+3
New +$216 ﹤0.01% 752

Other funds holding INSM

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Parkworth Wealth Management's INSM Position: Q2 2025 in Review

Parkworth Wealth Management reduced its Insmed (INSM) stake by 67% in Q2 2025, selling an estimated $153 and leaving 1 share worth $101. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

Parkworth Wealth Management first reported a position in INSM in Q4 2024 and has held it in 3 quarters since. The position peaked at $229 in Q1 2025. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

  • Parkworth Wealth Management held 1 share of Insmed worth $101 as of Q2 2025.
  • Parkworth Wealth Management sold 2 Insmed shares in Q2 2025, an estimated $153.
  • Insmed made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #1129 holding.
  • Parkworth Wealth Management first reported a position in Insmed in Q4 2024 and has held it in 3 quarters since.
  • Parkworth Wealth Management's Insmed position peaked at $229 in Q1 2025.
  • 516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.